Drugs Financial Statements From 2010 to 2026

DMAA Stock   10.44  0.01  0.1%   
Drugs Made's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Drugs Made's valuation are provided below:
Market Capitalization
349.9 M
Drugs Made In does not presently have any fundamental signals for analysis.
Check Drugs Made financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Drugs Made's main balance sheet or income statement drivers, such as , as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Drugs financial statements analysis is a perfect complement when working with Drugs Made Valuation or Volatility modules.
Check out the analysis of Drugs Made Correlation against competitors.

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Invested Capital3.4 K3.8 K4.1 K
Slightly volatile
Cash Per Share1.0E-41.0E-42.0E-4
Slightly volatile
Net Current Asset Value3.4 K3.8 K4.1 K
Slightly volatile
Income Quality0.50.550.6052
Slightly volatile
ROE1.571.771.9286
Slightly volatile
Current Ratio5.025.656.1624
Slightly volatile
Capex Per Share0.00.00.0
Slightly volatile
Graham Net Net1.0E-41.0E-41.0E-4
Slightly volatile
Interest Debt Per Share1.0E-41.0E-41.0E-4
Slightly volatile
Debt To Assets0.961.081.181
Slightly volatile
Total Debt To Capitalization1.261.421.5547
Slightly volatile
Return On Capital Employed1.571.761.9221
Slightly volatile
Quick Ratio5.025.656.1624
Slightly volatile
Cash Ratio1.361.531.6682
Slightly volatile
Debt Ratio0.961.081.181
Slightly volatile
Return On Equity1.571.771.9286
Slightly volatile

Drugs Made Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Working Capital3.4 K3.8 K4.1 K
Slightly volatile
Enterprise Value68.3 M76.8 M83.9 M
Slightly volatile

Drugs Fundamental Market Drivers

Short Percent Float0.0013
Short Percent0.0013

About Drugs Made Financial Statements

Drugs Made stakeholders use historical fundamental indicators, such as Drugs Made's revenue or net income, to determine how well the company is positioned to perform in the future. Although Drugs Made investors may analyze each financial statement separately, they are all interrelated. For example, changes in Drugs Made's assets and liabilities are reflected in the revenues and expenses on Drugs Made's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Drugs Made In. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Drugs Made In is a strong investment it is important to analyze Drugs Made's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Drugs Made's future performance. For an informed investment choice regarding Drugs Stock, refer to the following important reports:
Check out the analysis of Drugs Made Correlation against competitors.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Diversified Capital Markets space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Drugs Made. Projected growth potential of Drugs fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Drugs Made assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Drugs Made In is measured differently than its book value, which is the value of Drugs that is recorded on the company's balance sheet. Investors also form their own opinion of Drugs Made's value that differs from its market value or its book value, called intrinsic value, which is Drugs Made's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Drugs Made's market value can be influenced by many factors that don't directly affect Drugs Made's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Drugs Made's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Drugs Made should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Drugs Made's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.